(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.02%) $82.61
(0.79%) $2.05
(-0.53%) $2 345.10
(-1.01%) $27.38
(-0.14%) $960.20
(0.09%) $0.933
(0.10%) $10.99
(0.02%) $0.796
(0.01%) $93.31
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 14.14%
Live Chart Being Loaded With Signals
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...
Stats | |
---|---|
Dagens volum | 8 197.00 |
Gjennomsnittsvolum | 50 182.00 |
Markedsverdi | 9.34M |
EPS | $0 ( 2024-02-22 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-01 |
Last Dividend | $1 728.00 ( 2007-03-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.750 |
ATR14 | $0.0440 (0.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Horowitz Joshua | Buy | 16 438 | Common Stock |
2024-04-18 | Horowitz Joshua | Buy | 0 | Common Stock |
2024-04-18 | Horowitz Joshua | Sell | 0 | Common Stock |
2024-04-01 | Higgins Thomas T | Buy | 469 | Common Stock |
2024-04-01 | Higgins Thomas T | Sell | 74 | Common Stock |
INSIDER POWER |
---|
54.21 |
Last 97 transactions |
Buy: 971 558 | Sell: 254 579 |
NeuroMetrix Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
NeuroMetrix Inc Økonomi
Annual | 2023 |
Omsetning: | $5.90M |
Bruttogevinst: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2023 |
Omsetning: | $5.90M |
Bruttogevinst: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2022 |
Omsetning: | $8.26M |
Bruttogevinst: | $5.75M (69.65 %) |
EPS: | $-4.90 |
FY | 2021 |
Omsetning: | $8.25M |
Bruttogevinst: | $5.92M (71.75 %) |
EPS: | $-0.342 |
Financial Reports:
No articles found.
NeuroMetrix Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1 728.00 | 2007-03-28 |
Last Dividend | $1 728.00 | 2007-03-28 |
Next Dividend | $0 | N/A |
Payout Date | 2007-04-13 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1 728.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2007 | $1.000 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1.083 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.298 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.307 | 1.500 | -4.52 | -6.78 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 16.81 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 14.92 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.396 | 1.500 | 3.36 | 5.03 | [0.2 - 2] |
debtRatioTTM | 0.0112 | -1.500 | 9.81 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.63 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -2.06 | -4.11 | [0 - 20] |
debtEquityRatioTTM | 0.0120 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.669 | 1.000 | 2.19 | 2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.212 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -25.26 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.275 | 0.800 | -1.497 | -1.198 | [0.5 - 2] |
Total Score | -0.253 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -1.059 | 1.000 | -0.208 | 0 | [1 - 100] |
returnOnEquityTTM | -0.307 | 2.50 | -2.90 | -6.78 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -1.370 | -4.11 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0361 | 1.500 | -3.57 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -1.031 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.82 |
NeuroMetrix Inc
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.